Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells

Keyphrases

• Antiproliferative Activity 100%
• Sarcoma Cells 100%
• Ewing Sarcoma 100%
• Cell Viability 42%
• Therapeutic Strategies 28%
• Cell Cycle Arrest 28%
• Survivin 28%
• Caspase 3/7 Activity 28%
• Apoptosis 14%
• Cytotoxicity 14%
• Protein Expression 14%
• Small Molecule Inhibitors 14%
• Dose Effect 14%
• Flow Cytometry 14%
• Inhibition Rate 14%
• Anticancer Activity 14%
• Strong Correlation 14%
• Small Molecules 14%
• Activity Level 14%
• H9c2 Cells 14%
• Therapeutic Approaches 14%
• Combination Treatment 14%
• Annexin V Staining 14%
• H9c2 14%
• Tolfenamic Acid 14%
• Apoptosis Markers 14%
• Non-malignant Cells 14%
• Cardiomyocytes 14%
• Annexin V 14%
• Propidium Iodide 14%
• Relapsed Patients 14%
• Current Therapeutics 14%
• High Response 14%
• Cleaved PARP 14%
• Drug Resistance Reversal 14%
• Combination Therapeutics 14%
• Cell Cycle Assay 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Vincristine 100%
• Tolfenamic Acid 100%
• Ewing Sarcoma 100%
• Cell Viability 30%
• Lipocortin 5 20%
• Caspase 3 20%
• Survivin 20%
• Malignant Neoplasm 10%
• Flow Cytometry 10%
• Antiinfective Agent 10%
• Drug Resistance 10%
• Propidium Iodide 10%
• Cytotoxicity 10%